A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World

Clinical trial NCT07141914 · COMPLETED

Trial details

NCT number: NCT07141914
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Overweight Obesity Heart Failure (HF)Atherosclerotic Cardiovascular Disease (ASCVD)Primary Prevention

Start date: 2025-08-29
Primary completion: 2025-12-19
Enrollment: 285327

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.